145 related articles for article (PubMed ID: 33468929)
21. Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma.
Ielpo B; Duran H; Diaz E; Fabra I; Caruso R; Ferri V; Malavé L; Hidalgo M; Alvarez R; Plaza C; Quijano Y; Vicente E
Eur J Surg Oncol; 2016 Sep; 42(9):1394-400. PubMed ID: 26899943
[TBL] [Abstract][Full Text] [Related]
22. [A Case of Unresectable Locally Advanced Pancreatic Cancer Resulted in R0 Surgery after Chemotherapy].
Sasaki Y; Katayama H; Hosoda Y; Komoto I; Sugimoto T; Yanagihara K; Katsushima U; Kawai J; Kiyochi H; Nishiyama K; Okabe A; Oshima Y; Tsunekawa S; Ogura N; Taki Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1859-1861. PubMed ID: 29394800
[TBL] [Abstract][Full Text] [Related]
23. [R0 Resection by Distal Pancreatectomy with En Bloc Celiac Axis Resection after Down-Staging by FOLFIRINOX Therapy in a Case of Pancreas Cancer--Report of a Case].
Makino H; Kametaka H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1644-6. PubMed ID: 26805124
[TBL] [Abstract][Full Text] [Related]
24. [The Clinical Efficacy of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Carcinoma--Report of Two Cases Treated by Curative Pancreatectomy with Portal Vein Resection after Neoadjuvant Chemotherapy].
Imamura T; Ikoma H; Morimura R; Hatakeyama T; Kosuga T; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2379-81. PubMed ID: 26805370
[TBL] [Abstract][Full Text] [Related]
25. Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report.
Murase Y; Ban D; Maekawa A; Watanabe S; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Kudo T; Tanaka S; Tanabe M
Surg Case Rep; 2020 Dec; 6(1):302. PubMed ID: 33259017
[TBL] [Abstract][Full Text] [Related]
26. [Radical Resection of a Locally Advanced Unresectable Pancreatic Adenosquamous Carcinoma after Treatment with Systemic Chemotherapy].
Mashiko T; Nakano A; Masuoka Y; Yamamoto S; Ozawa S; Nakagohri T
Gan To Kagaku Ryoho; 2020 Aug; 47(8):1233-1235. PubMed ID: 32829362
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
Ettrich TJ; Berger AW; Perkhofer L; Daum S; König A; Dickhut A; Wittel U; Wille K; Geissler M; Algül H; Gallmeier E; Atzpodien J; Kornmann M; Muche R; Prasnikar N; Tannapfel A; Reinacher-Schick A; Uhl W; Seufferlein T
BMC Cancer; 2018 Dec; 18(1):1298. PubMed ID: 30594153
[TBL] [Abstract][Full Text] [Related]
28. [A case of curatively resected locally advanced pancreatic cancer with combined resection of the portal vein and common hepatic artery after neoadjuvant chemotherapy].
Kawaguchi K; Motoi F; Yokoyama S; Takemura S; Doi T; Nozawa Y; Fujishima F; Unno M; Kuroda F
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1875-7. PubMed ID: 24393951
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
Bednar F; Zenati MS; Steve J; Winters S; Ocuin LM; Bahary N; Hogg ME; Zeh HJ; Zureikat AH
Ann Surg Oncol; 2017 May; 24(5):1406-1413. PubMed ID: 27896518
[TBL] [Abstract][Full Text] [Related]
30. Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report.
Fujishiro T; Mashiko T; Masuoka Y; Yamada M; Furukawa D; Yazawa N; Kawashima Y; Ogawa M; Hirabayashi K; Nakagohri T
Surg Case Rep; 2018 Sep; 4(1):112. PubMed ID: 30203372
[TBL] [Abstract][Full Text] [Related]
31. [Resection of the remnant pancreas for recurrent pancreatic cancer after distal pancreatectomy-a case report].
Kinoshita S; Sho M; Akahori T; Nomi T; Yamato I; Hokutoh D; Yasuda S; Nakajima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1883-5. PubMed ID: 23267918
[TBL] [Abstract][Full Text] [Related]
32. [A 5-year survival case of locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemoradiation therapy].
Iseki M; Motoi F; Mizuma M; Hayashi H; Nakagawa K; Okada T; Otsuka H; Ottomo S; Sakata N; Fukase K; Yoshida H; Onogawa T; Naito T; Katayose Y; Egawa S; Unno M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1948-50. PubMed ID: 23267939
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant
Peterson SL; Husnain M; Pollack T; Pimentel A; Loaiza-Bonilla A; Westendorf-Overley C; Ratermann K; Anthony L; Desimone P; Goel G; Kudrimoti M; Dineen S; Tzeng CD; Hosein PJ
Anticancer Res; 2018 Jul; 38(7):4035-4039. PubMed ID: 29970528
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer.
Shibata Y; Uemura K; Kondo N; Sumiyoshi T; Okada K; Seo S; Otsuka H; Murakami Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2022 Jun; 15(3):635-641. PubMed ID: 35352239
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy.
Sherman WH; Hecht E; Leung D; Chu K
Oncologist; 2018 Jan; 23(1):4-e10. PubMed ID: 29212734
[TBL] [Abstract][Full Text] [Related]
36. Survival in borderline resectable and locally advanced pancreatic cancer is determined by the duration and response of neoadjuvant therapy.
Wijetunga AR; Chua TC; Nahm CB; Pavlakis N; Clarke S; Chan DL; Diakos C; Maloney S; Ashrafi-Zadeh A; Kneebone A; Hruby G; Jamieson NB; Gill A; Mittal A; Samra JS
Eur J Surg Oncol; 2021 Oct; 47(10):2543-2550. PubMed ID: 33952409
[TBL] [Abstract][Full Text] [Related]
37. [Radical resection of a locally advanced pancreatic tail adenosquamous carcinoma treated with S-1 and gemcitabine as neoadjuvant chemotherapy - a case report].
Sumiyoshi H; Matsushita A; Nakamura Y; Yamahatsu K; Katsuno A; Uchida E
Gan To Kagaku Ryoho; 2014 May; 41(5):669-72. PubMed ID: 24917020
[TBL] [Abstract][Full Text] [Related]
38. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).
Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G
Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842
[TBL] [Abstract][Full Text] [Related]
39. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial).
Maurel J; Sánchez-Cabús S; Laquente B; Gaba L; Visa L; Fabregat J; Povés I; Roselló S; Díaz-Beveridge R; Martín-Richard M; Rodriguez J; Sabater L; Conill C; Cambray M; Reig A; Ayuso JR; Valls C; Ferrández A; Bombí JA; Ginés A; García-Albéniz X; Fernández-Cruz L
Cancer Chemother Pharmacol; 2018 Dec; 82(6):935-943. PubMed ID: 30225601
[TBL] [Abstract][Full Text] [Related]
40. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
